Yahoo Finance Plus Shares of Roche are popping after its coronavirus test received FDA approval. Senior Scholar at John Hopkins Center for Health Security Dr. Amesh Adalja joins Seana Smith on The Ticker to discuss.
The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...
The last few years saw the markets go crazy. Between the COVID lockdowns and market crash, the rebound recovery, last year’s sustained bull run, and this year’s devastating first half that saw the bull turn into a bear. But in all of that, there have been stocks that have outperformed the market. These winning stocks have attracted attention from Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program. Among other things, Cramer has been following stocks which won big during the COVID cris
Hut 8 Mining Corp. (Nasdaq: HUT) (TSX: HUT), ("Hut 8" or the "Company") one of North America's largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure provider, is pleased to announce its financial results for the quarter ended June 30, 2022. All dollar figures are in Canadian Dollars ("CAD"), unless otherwise stated.
Persistent supply issues have deflated expectations for the Chinese automaker
Choosing stocks that can weather the storm and do well afterward, too, are the kinds of companies we should seek out, and the following trio of top tech stocks should outperform no matter what the market throws at it. Having shed its Warner Media division into the newly reconstituted Warner Bros Discovery in April, AT&T (NYSE: T) is now able to focus solely on its telecom operations and the rollout of its 5G network that will provide the industry with its next wave of growth. Although AT&T says it's not immune from the recessionary impacts affecting the broader economy, it's capable of managing through them and investing for the long-term benefit of customers and investors.
Like the telecom industry's other two stalwarts, it wasn't ready for this new competition that didn't exist a few years ago.
Among the dozens of stocks to enact splits this year are two industry leaders that scream value and one cash-rich company that's clobbering its shareholders.
The mercurial stock is down after earnings, but there is still plenty of reason for optimism for long-term investors.
Yahoo Finance reporter Allie Canal breaks down Disney's latest earnings results and how it's moving shares to the upside.
Yahoo Finance Live co-host Rachelle Akuffo looks at Rivian's stock ahead of its earnings report due out tomorrow.
Pan American Silver (PAAS) delivered earnings and revenue surprises of -121.43% and 16.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Senior Citizens League projects the annual cost-of-living adjustment for 2023 to come in at 9.6%, down slightly from the prior month's estimate as inflation cooled a bit.
Technology stocks have been among the best-performing sectors over the past month, second only to consumer discretionary stocks. Admittedly, the tech-laden Nasdaq 100 index is still down 19% in 2022, compared to a 13% decline in the S&P 500 and a 9% drop in the Dow Jones Industrial Average, but the rally indicates the sector is not dead. Tech stocks carried the market on its nearly decade-and-a-half bull run before they were frozen out at the end of last year as traders switched to seemingly more recession-resistant names.
(Bloomberg) -- Sanofi, GSK Plc and Haleon Plc extended their declines and have lost a combined $40 billion in market value since Tuesday’s close amid mounting concerns about litigations around recalled heartburn drug Zantac.Most Read from BloombergMusk Sells Another $6.9 Billion of Tesla Ahead of Twitter TrialDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsMedia Counts Differ With 11 Million Votes Collated: Kenya UpdateUS Inflation Runs Cooler Than Forecast, Easing Pressure on
After disruptions at GSK plc (NYSE: GSK), supplies of rotavirus infection vaccine in children have either run out in Kenya, Tanzania, Senegal, and Cameroon or are close, Reuters reported citing officials close to the roll-out. According to the World Health Organization, up to 200,000 children die each year of contagious infection. The infection causes severe, dehydrating gastroenteritis in children under five years. GSK confirmed a shortfall of around 4 million doses of its Rotarix vaccine in 20
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...
The housing market is changing fast. Act accordingly.
The latest analyst coverage could presage a bad day for Vertex Energy, Inc. ( NASDAQ:VTNR ), with the analysts making...
Four years after Siga Technologies (Nasdaq: SIGA) gained approval for a smallpox drug, the Corvallis company is gearing up to get the same antiviral into a clinical trial for monkeypox. Tpoxx, also known as tecovirimat, is the only drug available to treat the virus, though it is not yet approved in the U.S. for the disease. The Food and Drug Administration designated Tpoxx as an investigational drug for monkeypox, allowing it to be released from the Strategic National Stockpile only after prescribers jump through considerable hoops.
Yahoo Finance Live’s Brian Cheung explains July Consumer Price Index (CPI) data and what the report means for the Fed moving forward.
Yahoo Finance